Abstract Objective High molecular weight (HMW)-adiponectin has been found to be a better negative regulator of insulin resistance than total adiponectin. The aim of this study was to investigate the influence of HMWadiponectin on antiretroviral therapy (ART)-induced dyslipidemia in Japanese human immunodeficiency virus (HIV)-infected individuals. We also examined the effect of some antiretroviral drugs (ARVs) on adipocytes in vitro.
Introduction

Adiponectin is an adipokine secreted exclusively by adipocytes: this protein plays an important role in the control of systematic lipid metabolism and insulin sensitivity (1). Adiponectin forms multimers and is present in the serum as a trimer, hexamer, or as a high molecular weight (HMW) form (2). The HMW isoform most avidly binds to its receptors and stimulates AMP-activated protein kinase, one of the key molecules mediating the metabolic actions of adiponectin. Antiretroviral therapy (ART) has prolonged survival in human immunodeficiency virus (HIV)-infected individuals, but most individuals receiving ART develop metabolic abnormalities, which include dyslipidemia (elevated plasma triglycerides and cholesterol), increased visceral and dorsocervical adipose tissue and peripheral lipoatrophy (3). Although HIV infection itself (4) and nucleoside reverse transcriptase inhibitors (NRTI) (5-7) have been associated with metabolic abnormalities, there are increasing clinical and epidemiological data that suggest a central role for HIV protease inhibitors (PIs) in the causation of metabolic complications (8) and atazanavir (ATV) use has been associated with a decrease in hyperlipidemia, less insulin resistance and reversal of lipodystrophy (9).
Several recent clinical studies suggest that hypoadiponectinemia might play an important role in the causation of metabolic abnormalities associated with HIV infected individuals treated with PI-based ART, especially for those with lipodystrophy (8, 10, 11) 
Materials and Methods
Study population
The subjects evaluated in this study consisted 
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Statistical analysis
To evaluate the changes of BMI, serum triglyceride, LDLcholesterol, HDL-cholesterol, HMW-adiponectin after starting or changing ART, the one sample sign test was applied. The Mann-Whitney test was used to compare the serum HMW-adiponectin according to lipodystrophy. In vitro experiments were reproduced in at least three independent experiments. The results are presented as the mean ± SD. Significance was determined as described in the figure legends.
Results
The effect of ARV on the lipid profile and HMW adiponectin
The demographic and clinical characteristics for the 57 patients included in the study are shown in Table 1 (Fig. 1) .
The effect of ARV on adiponectin mRNA levels in differentiating 3T3-L1 cells
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ponectin mRNA level (Fig. 2B) . Similar results were obtained concerning the secretion of adiponectin into the culture medium (Fig. 2C) . (Fig. 3) . Fig. 1 
The effect of changing PI/EFV to ATV on adiponectin mRNA levels in 3T3-L1 cells
In the clinical study, the decreased adiponectin induced by PI/EFV was restored by switching the drugs to ATV. In addition, the precise effect of ATV on decreased adiponectin mRNA induced by PI/EFV was examined in vitro, using 3T3L1 cells. Adiponectin mRNA recovered significantly in mature adipocytes after switching drugs from EFV and NFV to ATV, but it did not recover on EFV-and NFV-treated preadipocytes and RTV-treated pre-and mature adipocytes
Discussion
Several studies have reported that metabolic syndrome is more common in subjects with HIV infection than in HIVnegative individuals. Although uncontrolled HIV replication can cause an adverse modification of the lipid metabolism, these modifications can be mainly induced by ART. The present study described the lipid abnormalities and lipodystrophy associated with ART. Hypertriglyceridemia was more common than abnormalities of HDL cholesterol and LDL cholesterol. LDL cholesterol increases were only observed in the population of group II (PI without ATV). These abnormalities were recovered by changing ART to the ATV containing regimen. In HIV-negative populations, the most common features associated with metabolic syndrome are obesity and hypertension. On the other hand, in HIVpositive populations, hypertriglyceridemia and hypertension are reported to be common components and the most frequent abnormalities that lead to metabolic syndrome (3).
That is why HIV-positive patients might need to have their ART regimen tailored to their lipid abnormalities. In this study, we also investigated the effect of ARVs on serum HMW-adiponectin, which has been reported to be a useful marker for evaluating insulin resistance and metabolic syndrome. This is the first study to investigate the influence of ARVs on the serum HMW-adiponectin levels in Japanese HIV-infected individuals. In general, the serum adiponectin levels are known to be inversely related to the adipose tissue mass (13). The serum adiponectin levels have been reported to rise when obese persons lose weight (14). We showed that adiponectin levels are relatively low in HIV-infected individuals with lipodystrophy who have a low fat mass, and this is consistent with previous reports (7, 10). These results suggest that the normal relationships between adiponectin concentration and adipose droplets appear to be lost or reversed in HIV-infected individuals. Since adiponectin expression is higher in subcutaneous fat than in visceral fat in humans (15), visceral fat accumulation and subcutaneous fat loss may thus lead to decreased adiponectin production both in lipoatrophic and lipohypertrophic patients. Therefore, fat redistribution may actually be responsible for the decreased adiponectin levels in HIV patients with lipodystrophy. As shown in
(C), it is certain that some of the patients without lipodystrophy had a decrease in serum HMWadiponectin levels, but these patients had dyslipidemia more frequently than the patients with either normal or high serum HMW-adiponectin without lipodystrophy (data not shown). Considering the fact that clinical HIV lipodystrophy has been reported to be associated with dyslipidemia, these patients might thus have the potential to be complicated by lipodystrophy. Therefore, the low levels of serum HMWadiponectin are correlated with lipodystrophy and/or dyslipidemia induced by PIs and NNRTI (EFV).
The present study also showed the direct effects of ARVs 
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